Oct
2026
Fiera Milano, Italy
Visit us
stand 14B42, Finished Dosage & Formulation & stand 14B43, Finished Dosage & Formulation
Cruise Passenger Services
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:Poland
-
On CPHI since:2015
-
Certificates:1
-
Employees:250 - 499
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 14D44, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Doxylamine 12.5, 25 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes
Noctis Bio & Noctis Bio Forte.
Category:Rx
Therapeutic class: Neurology.
Api + strength: Doxylamine hydrogen succinate 12.5/ 25.0 mg.
Form: film-coated tablets.
Indication: Insomnia
... -
Product Melatonin IR 2, 3, 5 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products including
Melatonin IR. Biofarm.
Category: OTC
Therapeutic class: Neurology
Api + strength: Melatonin 2, 3, 5mg,
Form: tablets.
Indication: sleeping disorders
Contact us for more information: export@biof... -
Product Famotidine 20 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes Famotidine Biofarm.
Category: OTC
Therapeutic class: Gastroenterology
Api + strength: Famotidine 20 mg.
Form: tablets.
Main Indication: indigestion, heartburn and acidity
Contact us for more inform... -
Product Vortioxetine 5,10,15,20 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes Vortioxetine.
Category:Rx
Therapeutic class: Psychiatric
Api + strength: Vortioxetine 5,10,15,20 mg
Form: film-coated tablets.
Indication: Major depressive episodes
Contact us for more inform... -
Product Thiocolchicoside 4,8 mg
Biofarm Sp. z o.o. offers a wide range of pharmaceutical products which includes Thiocolchicoside Biofarm 4, 8 mg. Therapeutic category:pain
Api + strength:Thiocolchicoside 4, 8 mg.
Form: film-coated tablets
Indication: treatment of painful muscular disorders
For more i...
Biofarm Sp. z o.o. Resources (1)
-
Brochure Portfolio 2025
Portfolio 2025
